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Potentially modifiable risk factors in the development of
Alzheimer's Disease
Abstract
This review summarizes empirical findings on major potentially modifiable risk factors in the
development of Alzheimer's disease (AD), drawing on data from longitudinal epidemiological studies
on the incidence of AD or any-cause dementia. Risk factors investigated to date include cognitive
ability, motivational ability, emotional health, physical activity, social activity and social network,
vascular risk factors, and nutrition. The authors find most empirical support for two main clusters of risk
factors that also represent potential targets for prevention. First, an active and stimulating lifestyle
including cognitive, social, and physical activities reduces risk of AD. Second, the absence of vascular
risk factors such as diabetes mellitus, hypertension, hypercholesterol, and obesity reduces risk of AD.
More prevention trials are warranted to investigate the preventive effects of an active and stimulating
lifestyle on the one hand, and vascular health, on the other, in delaying the onset of AD or slowing its
progression.
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Abstract
This article summarises empirical findings on major potentially modifiable risk factors in the development of Alzheimer’s disease (AD),
drawing on data from longitudinal epidemiological studies on the incidence of AD or any-cause dementia. Risk factors investigated to date
include cognitive ability, motivational ability, emotional health, physical activity, social activity and social network, vascular risk factors and
nutrition. The authors find most empirical support for two main clusters of risk factors that also represent potential targets for prevention.
First, an active and stimulating lifestyle including cognitive, social, and physical activities reduces the risk of AD. Second, the absence of
vascular risk factors such as diabetes, hypertension, hypercholesterol and obesity reduces the risk of AD. More prevention trials are
warranted to investigate the preventative effects of an active and stimulating lifestyle on the one hand, and vascular health on the other,
in delaying the onset of AD or slowing its progression.
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As the number of people over 65 years of age continues to rise
worldwide, preserving the cognitive health of older adults has
become a major societal challenge. The global prevalence of
Alzheimer’s disease (AD) was estimated at 26.55 million in 2006 and
is expected to quadruple over the next 40 years.1 However, research
on successful ageing challenges the popular notion that ageing
invariably involves a decline in cognitive functioning and quality of life,
and has identified factors that can increase individuals’ ‘health span’
as they enter later life.2 If onset or progression of AD could be delayed
by only one year, there would be 9.2 million fewer cases of the
disease in 2050.1 The goal of current research on AD and other
dementias is thus to identify both biological and psychological factors
that may help people to maintain or enhance their cognitive health in
older age and to prevent or postpone the development of dementia.
The most well-established risk factors for AD and other dementias are
old age, genetic susceptibility, familial aggregation and female sex.
However, modifiable risk factors are more important for the
development of prevention strategies. In this article, we summarise
empirical findings on the major modifiable risk factors of AD. We base
our overview and conclusions on several recent review papers as well
as on a systematic review of our own, which aimed to include all
published studies providing an estimate of the incidence of AD or
dementia (‘relative risk’) associated with the risk factor examined (see
Table 1). We included only longitudinal studies whose results were
adjusted at least for age, sex, and education. Due to space
restrictions, we cite only example studies and summarise the findings
of our review in Table 1. The interested reader is referred to the review
papers presented in Table 1 and to more general overview articles.3–6
Note that in epidemiological studies, AD is usually diagnosed on the
basis of clinical features rather than neuropathological evidence.
Cognitive Ability
Dozens of longitudinal studies suggest that lower pre-morbid
cognitive ability increases the risk of AD and dementia. Four different
measures have been used to estimate pre-morbid cognitive ability:
educational level, pre-morbid performance in cognitive tests, amount
of cognitive activity and occupational attainment.
Educational Level
Educational level is usually assessed as a two- or three-category
variable (e.g. <8 years, ≥8 years). We identified 15 studies, 11 of which
found a significantly increased risk of AD or any-cause dementia in
less educated individuals.7,8 A recent meta-analysis calculated a
relative risk of low versus high educational level of 1.8 (95%
confidence interval [CI] 1.4–2.3) for AD and 1.6 (95% CI: 1.3–2.0) for all
dementias.9 Although there is strong evidence that education 
to a low standard is a risk factor for AD, the mechanisms underlying
this association are not yet clear. Most authors explain the protective
effect of education in terms of cognitive reserve:10 education is
thought to stimulate underlying brain networks and make them more
efficient and flexible. In individuals with higher cognitive reserve, the
underlying brain pathology may not become clinically manifest until
later because their brain networks are more capable or because
different, intact networks are used to replace or bypass the disrupted
networks. Other explanations of the association between education
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and dementia suggest that education is strongly linked with early life
circumstances (e.g. socioeconomic status), motivational ability or
health behaviour (e.g. nutrition and physical activity).
Pre-morbid Intelligence
Two studies using a more direct measure of pre-morbid intelligence
found a significant association between performance in cognitive
tests and risk of AD or dementia. In one study, a measure of verbal
intelligence (which is considered to provide a good estimate of pre-
morbid intelligence) applied at baseline was a better predictor of
incident dementia four years later than was educational level.11
Another study in which several memory and intelligence tests were
applied at baseline found that lower memory function predicted
higher risk of dementia 22 years later.12
Cognitive Activity
Seven studies were identified that investigated the relation between
participation in cognitive activities (e.g. reading books and newspapers,
writing, studying, doing crossword puzzles) in mid- to late life and risk of
AD and dementia. Almost all (six) studies found a reduced risk of AD in
individuals who frequently engaged in cognitive activities (e.g. relative
risk 0.4, 95% CI 0.2–0.7), even when the APOE 4 allele was controlled.13
Occupational Attainment
Occupational activities may provide a source of continued cognitive
stimulation, contributing to the development of cognitive reserve. 
Five of the six longitudinal studies identified used a two-category
variable of occupational attainment, e.g. low level (unskilled, semi-
skilled) versus high level (self-employed, professional, skilled). Only
two of these five studies found that people who worked in low-skilled
occupations had a higher risk of AD or dementia (e.g. relative risk 2.3,
95% CI 1.3–3.8).14 A different approach is to rate each occupation in
terms of the complexity of work with data, people and things. One
longitudinal study found a decreased risk of all-cause dementia, but
not AD, in people who have worked in occupations characterised by
high complexity of work with people and things.15
In sum, lower cognitive ability seems to be a risk factor for AD and
dementia in general. Results differ depending on the measurement
approach. Although educational level, pre-morbid intelligence and
cognitive activities are clearly linked to AD and any-cause dementia,
findings for occupational attainment are less conclusive, presumably
because this variable depends not only on cognitive ability, but also
on motivational, social and other abilities.16
Motivational Ability
The concept of brain reserve is more comprehensive than that of
cognitive reserve. Brain reserve enables the brain to tolerate
neuropathological dementia-related changes without clinical
manifestation. In the case of behavioural brain reserve,17 behavioural
and mental training throughout life is assumed to promote the more
efficient use of brain networks and compensation of disrupted
networks. We have suggested that not only pre-morbid cognitive ability
but also pre-morbid motivational ability contributes to brain reserve.16
We hypothesise that people with strong motivational abilities (e.g.
decision regulation, activation regulation, motivation regulation and
self-efficacy) have a lower risk of AD. Epidemiological research has
shown that motivational ability is associated with some mental and
physical disorders and risk factors for AD (e.g. depressive symptoms,
educational and occupational attainment, physical activity), suggesting
a more specific link to the development of AD.16 We are currently
conducting longitudinal studies to investigate this relationship, partly in
co-operation with the German Competence Network on Dementia.18
Conscientiousness – one component of the five-factor model of
personality – is a related construct that can be defined as the
tendency to control impulses and to be goal-directed. Whereas
motivational ability is assumed to be modifiable through training,
conscientiousness is thought to be a stable personality trait. One
longitudinal study found that relative risk of AD is slightly lower in
highly conscientious individuals, even after adjusting for numerous
control variables (relative risk 0.97, 95% CI 0.93–0.997).19
Emotional Health
A recent meta-analysis on the association of depression and risk of
AD identified 11 longitudinal studies.20 Only half (five) of these studies
found that the risk of AD was significantly higher in individuals who
reported depressive symptoms earlier in life.21 The mean risk in this
meta-analysis was 1.9 (95% CI 1.6–2.3), suggesting that there is a link
between depression and risk of AD. Depression often accompanies
early dementia and may therefore be an early prodrome of dementia
rather than an independent risk factor for AD. However, findings show
that the interval between diagnoses of depression and AD is positively
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Table 1: Summary of Studies Investigating Potential 
Risk Factors for Alzheimer’s Disease
Potential Risk Factor Significant No Review or Example 




Educational level 11 4 9, 45 7, 8
Pre-morbid IQ 2 0 11, 12
Cognitive activity 6 1 46 13
Occupational 2 4 45 14
attainment
Motivational Ability
Conscientiousness 1 0 19
Emotional Health
Depression 5 6 20 21
Neuroticism 3 0 22
Physical Activity 12 4 46 23, 24
Social Activity
Social activity 4 0 46 25
Social network 4 0 46 26
Vascular Risk Factors
Diabetes 6 5 27 28
Hypertension 5 6 27 29
Hypercholesterol 2 2 27 30
Obesity 1 4 27 31
Nutrition
Homocysteine 3 1 6, 40 33
Vitamin B6 1 2 6, 40 34
Vitamin B12 0 4 6, 40 34
Folate 5 1 6, 40 34
Vitamin E 3 4 6, 40 35
Vitamin C 1 5 6, 40 35
Flavonoids 0 3 6, 40 35
Beta-carotene 0 5 6, 40 35
Polyunsaturated fat 3 1 6, 40 36
Diverse diet 2 0 6, 40 37, 38
Fish 2 1 6, 40 39
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related to risk of AD, indicating that depression seems to be a risk
factor for rather than a prodrome of AD.20
One possible explanation for the association between depression and
risk of AD is that depression may lead to increased cortisol levels in 
the hippocampus, and that prolonged exposure to cortisol contributes
to hippocampal atrophy and, in the long run, to AD. If this is the case,
people who are susceptible to psychological stress such as depression
(i.e. people with the personality trait of neuroticism) should have a
higher risk of AD. Three longitudinal studies investigated this association
and found that pre-morbid proneness to psychological stress slightly
increases the risk of AD (relative risk 1.05, 95% CI 1.01–1.09).22
Physical Activity
Sixteen studies were identified that investigated the relationship
between participation in regular (daily) physical activities (e.g. walking,
dancing, swimming) in mid- to late life and risk of AD and dementia.
Most (12) studies found a reduced risk of AD in individuals who
frequently participated in physical activities (e.g. relative risk 0.6, 95%
CI 0.3–0.9).23 The majority of these studies investigated the effect of
physical activity in old age. However, a protective effect of physical
activity in middle age has also been reported.24 Several possible
mechanisms may underlie this association, including reduction of
vascular risk factors, promotion of brain plasticity and brain reserve
and general cognitive ability resulting in better health behaviour.
Social Activity and Social Network
Several longitudinal studies have investigated the protective effects
of social factors such as social activity and social network on risk of
AD and dementia.
Social Activity
Four studies were identified that investigated the relationship between
participation in regular social activities (e.g. going to the theatre,
participating in social groups, visiting friends) in late life and risk of
dementia. All studies found a reduced risk of dementia in individuals
who frequently participated in social activities (e.g., relative risk 0.6,
95% CI 0.4–0.9).25 Several possible mechanisms may underlie this
association, including promotion of brain plasticity and brain reserve,
and emotional health resulting from fulfilling relationships.
Social Network
The latter hypothesis can also be tested by investigating the social
network as a risk factor (e.g. being single or divorced versus married).
Four studies were identified that investigated the relationship
between social network and risk of dementia. All studies found an
increased risk of dementia in individuals with poorer social networks
(e.g. relative risk 2.3, 95% CI 1.3–4.7).26 Rich social networks provide
emotional support and cognitive simulation.
Vascular Risk Factors
The components of metabolic syndrome – diabetes, hypertension,
hypercholesterol and obesity – are well-known risk factors for
cardiovascular disease. There is also accumulating evidence that they
are risk factors for AD and dementia in general. Treatment of these
conditions is thus an important target for prevention of dementia.
Diabetes
A recent systematic review identified 13 studies investigating the
relationship between diabetes in mid- to late life and risk of AD or of
any-cause dementia.27 Six of the 11 studies focusing on AD found an
increased risk for people with diabetes (e.g. relative risk 1.8, 95% CI
1.1–2.9).28 Five of the nine studies covering any-cause dementia
reported an increased risk for people with diabetes (e.g. relative risk
1.5, 95% CI 1.0–2.2).28 There was no clear difference in findings for
diabetes in mid- versus late life.
Hypertension
Five of 11 studies found an increased risk of AD in people with
hypertension (e.g. relative risk 4.5, 95% CI 1.5–13.1).29 Five of six
studies found an increased risk of any dementia (e.g. relative risk 4.0,
95% CI 1.6–10.3).29 However, some studies showed that either
elevated systolic or elevated diastolic blood pressure was associated
with an increased risk of AD. There was a marked difference in
findings for hypertension in mid- versus late life. All studies assessing
blood pressure at mid-life found a significant association between
hypertension and AD/dementia, compared with only one study
assessing blood pressure in late life.
Hypercholesterol
Two of four studies found an increased risk of AD in people with
elevated total cholesterol (e.g. relative risk 2.8, 95% CI 1.2–6.7).30 Two
of six studies found an increased risk of any dementia (e.g. relative
risk 2.6, 95% CI 1.2–6.0).30 The studies reporting a significant
association between high cholesterol and risk of AD/dementia
assessed cholesterol levels in mid-life; all others assessed cholesterol
levels in late life.
Obesity
Only one of five studies found an increased risk of AD in people with
obesity (relative risk 1.4, 95% CI 1.2–1.6).31 Five of seven studies
found an increased risk of any dementia (relative risk 1.1, 95% CI
1.04–1.2).31 Generally, studies that measured weight at mid-life
compared with late life showed a more consistent association and a
higher risk of dementia.
In conclusion, the deleterious effects of vascular risk factors that are
already present in mid-life seem relatively clear. These factors may
play a causal role in AD by influencing neurodegenerative processes
in the brain. Negative effects of vascular risk factors present in late
life seem less evident. Findings also show that the risk of AD and
dementia increases with the number of vascular risk factors.32
Nutrition
Several nutritional factors have been investigated as potential risk
factors for AD and dementia in recent years. The question is which
nutrients are essential for the healthy functioning of the brain.
Vitamins
Three of four studies (see reference 6 for an overview) found an
increased risk of AD in people with a high homocysteine level (e.g.
relative risk 1.8, 95% CI 1.3–2.5).33 Vitamin B6, vitamin B12 and folate
have often been investigated simultaneously. Six studies were
identified that tested the associations between these vitamins and
risk of AD.6 In five of these studies, high folate intake in late life was
found to reduce the risk of AD (e.g. relative risk 0.4, 95% CI 0.2–0.8).34
Vitamin B6 intake was associated with risk of AD in only one of four
studies, and B12 intake in none of the studies.
34 It has also been
speculated that intake of antioxidative vitamins E, C, flovoid and beta-
carotene might influence risk of AD. Ten studies on these associations
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were identified.6 The most conclusive evidence was found for vitamin
E, although only three of seven studies showed a reduced risk of AD
in people with a high vitamin E intake (e.g. relative risk 0.8, 95% CI
0.7–1.0).35 Only one of six studies found evidence for an association
with vitamin C intake,35 and no studies found associations with
flovoids or beta-carotene.
Fat Intake
Fatty acid intake may affect the brain though inflammatory or
artherosclerotic mechanisms; to date, five studies have investigated
the association with dementia.6 A high intake of polyunsaturated fats
in mid- to late life was associated with a reduced risk of AD in three
of four studies, whereas a high intake of saturated fats was
associated with an increased risk of AD in two of three studies (e.g.
relative risk 2.2, 95% CI 1.1–4.7).36
Dietary Pattern
Finally, a diverse diet including daily fruits and vegetables and two to
three servings of fish per week37 and a Mediterranean-style diet rich
in fish, fruits and vegetables are known to be associated with lower
risk of AD.38 Two of three studies investigating the association
between weekly fish intake and risk of AD found a reduced risk (e.g.
relative risk 2.2, 95% CI 1.1–4.7).39 In sum, some longitudinal studies
suggest that higher intakes of folate, vitamin B6, vitamin E,
polyunsaturated fats, fruits and vegetables rich in antioxidants and
fish are related to lower risk of AD, but results are inconsistent.40
Conclusion
Based on this brief overview of the empirical findings on potentially
modifiable risk factors for AD, two main clusters of risk factors and
prevention targets can be highlighted (see Table 1). First, an active
and stimulating lifestyle including cognitive, social and physical
activities reduces risk of AD, presumably by increasing brain reserve
or reducing depression. Second, the absence of vascular risk factors
reduces risk of AD, presumably by preventing neurodegenerative
processes in the brain. However, there is currently not enough
empirical evidence from longitudinal studies for serious conclusions
to be drawn about other potential risk factors (motivational ability,
emotional health and nutrition).40 Again, it is important to note that
incident AD or dementia cases were assessed on the basis of clinical
features rather than neuropathological evidence.
To go one step further, results from randomised clinical trials (RCTs)
on dementia prevention are not always as encouraging as results
from the epidemiological studies cited. The existing RCTs – which are
scarce in number – partially support the recommendations of physical
exercise41 as well as antihypertensive42 and cholesterol-lowering43
treatments to prevent the development of AD. There is little support
from RCTs for preventative effects of cognitive training,44 diabetes
treatment6 or nutritional strategies.40 We found no RCTs testing the
influence of social activity and social network or treatment of
depression on dementia risk. More prevention trials are warranted to
investigate the preventative effects of an active and stimulating
lifestyle on the one hand and vascular health on the other in delaying
the onset of AD or slowing its progression. Appropriate preventative
measures would potentially reduce by millions the number of people
with this devastating disease.1 n
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